Funded Biomarker Testing
1 items
Reflex testing on cases of adult patients with persistent, recurrent, or metastatic cervical cancer when treatment is being considered
Funded Biomarker Disease Site: Cervix
Biomarker: PD-L1 (CPS ≥1)
Testing Method:Immunohistochemistry (IHC)
Testing Site: Hamilton Health Sciences, London Health Sciences Centre, St. Joseph's Healthcare Hamilton, Sunnybrook Health Sciences Centre, Unity Health - St. Michael's Hospital, University Health Network, William Osler Health System